May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Intravitreal Triamcinolone for Refractory Pseudophakic Cystoid Macular Edema
M.L. Nelson; A. Martidis; D.J. Spinak; M. Liu; A. Sivalingam; J.L. Federman
Author Affiliations & Notes
  • M.L. Nelson
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • A. Martidis
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • D.J. Spinak
    Ophthalmology, Temple University, Philadelphia, PA, United States
  • M. Liu
    Ophthalmology, Temple University, Philadelphia, PA, United States
  • A. Sivalingam
    Ophthalmology, Temple University, Philadelphia, PA, United States
  • J.L. Federman
    Ophthalmology, Temple University, Philadelphia, PA, United States
  • Footnotes
    Commercial Relationships  M.L. Nelson, None; A. Martidis, None; D.J. Spinak, None; M. Liu, None; A. Sivalingam, None; J.L. Federman, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 226. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Intravitreal Triamcinolone for Refractory Pseudophakic Cystoid Macular Edema
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      M.L. Nelson, A. Martidis, D.J. Spinak, M. Liu, A. Sivalingam, J.L. Federman; Intravitreal Triamcinolone for Refractory Pseudophakic Cystoid Macular Edema . Invest. Ophthalmol. Vis. Sci. 2003;44(13):226.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: Evaluate the effectiveness of intravitreal triamcinolone acetonide in the treatment of refractory pseudophakic cystoid macular edema Methods: Records of fifteen patients treated with intravitreal triamcinolone acetonide for postoperative pseudophakic CME unresponsive to conventional therapy were analyzed retrospectively. Results: Sixteen eyes in fifteen patients had refractory pseudophakic CME that was treated with 4mg of intravitreal triamcinolone acetonide. Mean visual acuity improved an average of 3.0 lines (range 0-5 lines). Average follow-up was 5.6 months. One eye required retreatment. Four eyes received optical coherence tomography (OCT) before and after treatment. Retinal thickness decreased an average of 42% in these four eyes. Four eyes required treatment with topical ocular hypotensives due to a steroid response. One eye had a retinal detachment, which was successfully managed. Conclusions: Intravitreal triamcinolone acetonide appears to be a promising treatment for eyes with refractory pseudophakic CME. Further study is warranted to determine long-term efficacy and safety.

Keywords: inflammation • treatment outcomes of cataract surgery • macula/fovea 
© 2003, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept